Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.

Mauro ViganòAlessandro LoglioSara LabancaSerena ZaltronFrancesco CastelliPietro AndreoneVincenzo MessinaRoberto GangaNicola CoppolaAldo MarroneMaurizio RusselloAlfredo MarzanoAlessandra TucciGloria TalianiMassimo FasanoStefano FagiuoliErica VillaFabrizio BronteTeresa SantantonioGiuseppina BrancaccioVincenzo OcchipintiFloriana FacchettiGlenda GrossiMariagrazia RumiPietro Lampertico

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

Entecavir is an effective and safe rescue strategy for CHB patients who develop renal dysfunction during long-term TDF treatment.

Keyphrases

end stage renal disease
chronic kidney disease
oxidative stress
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
patient reported outcomes